Gurugram, India

Neera Tiwari

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 1995-2015.


% Patents Active = 50.0

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • New Delhi, IN (1995)
  • Qutab Enclave, IN (1996)
  • Gurgaon, IN (2013 - 2015)

Company Filing History:


Years Active: 1995-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Neera Tiwari: Innovator in Pharmaceutical Chemistry

Introduction

Neera Tiwari is a prominent inventor based in Gurgaon, India. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug preparation. With a total of 4 patents to her name, Tiwari has established herself as a key figure in her industry.

Latest Patents

Among her latest innovations are two notable patents. The first is a process for the preparation of pure meropenem trihydrate, which is crucial for ensuring the efficacy and safety of this antibiotic. The second patent involves a process for the preparation of sterile doripenem, another important antibiotic that plays a vital role in treating various infections.

Career Highlights

Neera Tiwari is currently employed at Ranbaxy Laboratories, Inc., where she continues to push the boundaries of pharmaceutical research. Her work has not only advanced the field but has also contributed to the development of essential medications that improve patient outcomes.

Collaborations

Throughout her career, Tiwari has collaborated with esteemed colleagues, including Jag Mohan Khanna and Yatendra Kumar. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Neera Tiwari's contributions to pharmaceutical chemistry exemplify her dedication to innovation and excellence. Her patents reflect her commitment to improving healthcare through advanced drug preparation processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…